Loading…

Synergistic effect of VEGF and SDF-1α in endothelial progenitor cells and vascular smooth muscle cells

Vascular endothelial growth factor (VEGF) is a potent agonist of angiogenesis that induces proliferation and differentiation of endothelial progenitor cells (EPCs) after vascular injury. Previous studies have suggested that stromal cell-derived factor 1-alpha (SDF-1α) and VEGF have a synergistic eff...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2022-07, Vol.13, p.914347-914347
Main Authors: Yang, Haiyan, He, Cancan, Bi, Yang, Zhu, Xu, Deng, Dan, Ran, Tingting, Ji, Xiaojuan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c442t-ad2e13759f2cb2ef79e0817704a9473c0f285c6ca1f2bb87087e7a71c96a21f83
cites cdi_FETCH-LOGICAL-c442t-ad2e13759f2cb2ef79e0817704a9473c0f285c6ca1f2bb87087e7a71c96a21f83
container_end_page 914347
container_issue
container_start_page 914347
container_title Frontiers in pharmacology
container_volume 13
creator Yang, Haiyan
He, Cancan
Bi, Yang
Zhu, Xu
Deng, Dan
Ran, Tingting
Ji, Xiaojuan
description Vascular endothelial growth factor (VEGF) is a potent agonist of angiogenesis that induces proliferation and differentiation of endothelial progenitor cells (EPCs) after vascular injury. Previous studies have suggested that stromal cell-derived factor 1-alpha (SDF-1α) and VEGF have a synergistic effect on vascular stenosis. The aim of the present study was to investigate whether VEGF and SDF-1α act synergistically in EPCs and vascular smooth muscle cells (VSMCs). In this study, EPCs were isolated from rat bone marrow and their morphology and function were studied. Subsequently, VEGF was delivered into EPCs using an adenoviral vector. Tube formation, migration, proliferation, and apoptosis of VEGF-overexpressing EPCs was analyzed. Then, EPCs were co-cultured with VSMCs in the presence or absence of SDF-1α, the migration, proliferation, apoptosis, and differentiation capacity of EPCs and VSMCs were analyzed respectively. The isolated EPCs showed typical morphological features, phagocytic capacity, and expressed surface proteins. While stable expression of VEGF remarkably enhanced tube formation, migration, and proliferation capacity of EPCs, apoptosis was decreased. Moreover, the proliferation, migration, and differentiation capacity of EPCs in the co-cultured model was enhanced in the presence of SDF-1α, and apoptosis was decreased. However, these effects were reversed in VSMCs. Therefore, our results showed that VEGF and SDF-1α synergistically increased the migration, differentiation, and proliferation capabilities of EPCs, but not VSMCs. This study suggests a promising strategy to prevent vascular stenosis.
doi_str_mv 10.3389/fphar.2022.914347
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_49ed786a0fe64710bc7ca4e29069b76e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_49ed786a0fe64710bc7ca4e29069b76e</doaj_id><sourcerecordid>2697091823</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-ad2e13759f2cb2ef79e0817704a9473c0f285c6ca1f2bb87087e7a71c96a21f83</originalsourceid><addsrcrecordid>eNpVkctO3DAUhiPUChDlAbrzspsMvsWXTaWKMhQJqQvabq0T5zgTlMRTO0HisfoifSYyE1QVb3z79Pkc_0XxkdGNEMZehf0O0oZTzjeWSSH1SXHOlBKlNYy_-299Vlzm_EiXIawVSp4WZ6KybNnx86J9eB4xtV2eOk8wBPQTiYH8urndEhgb8vB1W7K_f0g3EhybOO2w76An-xRbHLspJuKx7_ORfYLs5x4SyUNcSDLM2fe4Ah-K9wH6jJev80Xxc3vz4_pbef_99u76y33ppeRTCQ1HJnRlA_c1x6AtUsO0phKs1MLTwE3llQcWeF0bTY1GDZp5q4CzYMRFcbd6mwiPbp-6AdKzi9C540FMrYO09NqjkxYbbRTQgEpqRmuvPUjklipba4WL6_Pq2s_1gI3HcUrQv5G-vRm7nWvjk7NCVKY6FPPpVZDi7xnz5IYuH74DRoxzdlxZTS0zXCwoW1GfYs4Jw79nGHWHvN0xb3fI2615ixc79Z72</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2697091823</pqid></control><display><type>article</type><title>Synergistic effect of VEGF and SDF-1α in endothelial progenitor cells and vascular smooth muscle cells</title><source>Open Access: PubMed Central</source><creator>Yang, Haiyan ; He, Cancan ; Bi, Yang ; Zhu, Xu ; Deng, Dan ; Ran, Tingting ; Ji, Xiaojuan</creator><creatorcontrib>Yang, Haiyan ; He, Cancan ; Bi, Yang ; Zhu, Xu ; Deng, Dan ; Ran, Tingting ; Ji, Xiaojuan</creatorcontrib><description>Vascular endothelial growth factor (VEGF) is a potent agonist of angiogenesis that induces proliferation and differentiation of endothelial progenitor cells (EPCs) after vascular injury. Previous studies have suggested that stromal cell-derived factor 1-alpha (SDF-1α) and VEGF have a synergistic effect on vascular stenosis. The aim of the present study was to investigate whether VEGF and SDF-1α act synergistically in EPCs and vascular smooth muscle cells (VSMCs). In this study, EPCs were isolated from rat bone marrow and their morphology and function were studied. Subsequently, VEGF was delivered into EPCs using an adenoviral vector. Tube formation, migration, proliferation, and apoptosis of VEGF-overexpressing EPCs was analyzed. Then, EPCs were co-cultured with VSMCs in the presence or absence of SDF-1α, the migration, proliferation, apoptosis, and differentiation capacity of EPCs and VSMCs were analyzed respectively. The isolated EPCs showed typical morphological features, phagocytic capacity, and expressed surface proteins. While stable expression of VEGF remarkably enhanced tube formation, migration, and proliferation capacity of EPCs, apoptosis was decreased. Moreover, the proliferation, migration, and differentiation capacity of EPCs in the co-cultured model was enhanced in the presence of SDF-1α, and apoptosis was decreased. However, these effects were reversed in VSMCs. Therefore, our results showed that VEGF and SDF-1α synergistically increased the migration, differentiation, and proliferation capabilities of EPCs, but not VSMCs. This study suggests a promising strategy to prevent vascular stenosis.</description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2022.914347</identifier><identifier>PMID: 35910392</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>endothelial progenitor cell ; Pharmacology ; stromal cell-derived factor-1α ; synergistic effect ; vascular endothelial growth factor ; vascular smooth muscle cells</subject><ispartof>Frontiers in pharmacology, 2022-07, Vol.13, p.914347-914347</ispartof><rights>Copyright © 2022 Yang, He, Bi, Zhu, Deng, Ran and Ji. 2022 Yang, He, Bi, Zhu, Deng, Ran and Ji</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-ad2e13759f2cb2ef79e0817704a9473c0f285c6ca1f2bb87087e7a71c96a21f83</citedby><cites>FETCH-LOGICAL-c442t-ad2e13759f2cb2ef79e0817704a9473c0f285c6ca1f2bb87087e7a71c96a21f83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335858/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335858/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Yang, Haiyan</creatorcontrib><creatorcontrib>He, Cancan</creatorcontrib><creatorcontrib>Bi, Yang</creatorcontrib><creatorcontrib>Zhu, Xu</creatorcontrib><creatorcontrib>Deng, Dan</creatorcontrib><creatorcontrib>Ran, Tingting</creatorcontrib><creatorcontrib>Ji, Xiaojuan</creatorcontrib><title>Synergistic effect of VEGF and SDF-1α in endothelial progenitor cells and vascular smooth muscle cells</title><title>Frontiers in pharmacology</title><description>Vascular endothelial growth factor (VEGF) is a potent agonist of angiogenesis that induces proliferation and differentiation of endothelial progenitor cells (EPCs) after vascular injury. Previous studies have suggested that stromal cell-derived factor 1-alpha (SDF-1α) and VEGF have a synergistic effect on vascular stenosis. The aim of the present study was to investigate whether VEGF and SDF-1α act synergistically in EPCs and vascular smooth muscle cells (VSMCs). In this study, EPCs were isolated from rat bone marrow and their morphology and function were studied. Subsequently, VEGF was delivered into EPCs using an adenoviral vector. Tube formation, migration, proliferation, and apoptosis of VEGF-overexpressing EPCs was analyzed. Then, EPCs were co-cultured with VSMCs in the presence or absence of SDF-1α, the migration, proliferation, apoptosis, and differentiation capacity of EPCs and VSMCs were analyzed respectively. The isolated EPCs showed typical morphological features, phagocytic capacity, and expressed surface proteins. While stable expression of VEGF remarkably enhanced tube formation, migration, and proliferation capacity of EPCs, apoptosis was decreased. Moreover, the proliferation, migration, and differentiation capacity of EPCs in the co-cultured model was enhanced in the presence of SDF-1α, and apoptosis was decreased. However, these effects were reversed in VSMCs. Therefore, our results showed that VEGF and SDF-1α synergistically increased the migration, differentiation, and proliferation capabilities of EPCs, but not VSMCs. This study suggests a promising strategy to prevent vascular stenosis.</description><subject>endothelial progenitor cell</subject><subject>Pharmacology</subject><subject>stromal cell-derived factor-1α</subject><subject>synergistic effect</subject><subject>vascular endothelial growth factor</subject><subject>vascular smooth muscle cells</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkctO3DAUhiPUChDlAbrzspsMvsWXTaWKMhQJqQvabq0T5zgTlMRTO0HisfoifSYyE1QVb3z79Pkc_0XxkdGNEMZehf0O0oZTzjeWSSH1SXHOlBKlNYy_-299Vlzm_EiXIawVSp4WZ6KybNnx86J9eB4xtV2eOk8wBPQTiYH8urndEhgb8vB1W7K_f0g3EhybOO2w76An-xRbHLspJuKx7_ORfYLs5x4SyUNcSDLM2fe4Ah-K9wH6jJev80Xxc3vz4_pbef_99u76y33ppeRTCQ1HJnRlA_c1x6AtUsO0phKs1MLTwE3llQcWeF0bTY1GDZp5q4CzYMRFcbd6mwiPbp-6AdKzi9C540FMrYO09NqjkxYbbRTQgEpqRmuvPUjklipba4WL6_Pq2s_1gI3HcUrQv5G-vRm7nWvjk7NCVKY6FPPpVZDi7xnz5IYuH74DRoxzdlxZTS0zXCwoW1GfYs4Jw79nGHWHvN0xb3fI2615ixc79Z72</recordid><startdate>20220715</startdate><enddate>20220715</enddate><creator>Yang, Haiyan</creator><creator>He, Cancan</creator><creator>Bi, Yang</creator><creator>Zhu, Xu</creator><creator>Deng, Dan</creator><creator>Ran, Tingting</creator><creator>Ji, Xiaojuan</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220715</creationdate><title>Synergistic effect of VEGF and SDF-1α in endothelial progenitor cells and vascular smooth muscle cells</title><author>Yang, Haiyan ; He, Cancan ; Bi, Yang ; Zhu, Xu ; Deng, Dan ; Ran, Tingting ; Ji, Xiaojuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-ad2e13759f2cb2ef79e0817704a9473c0f285c6ca1f2bb87087e7a71c96a21f83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>endothelial progenitor cell</topic><topic>Pharmacology</topic><topic>stromal cell-derived factor-1α</topic><topic>synergistic effect</topic><topic>vascular endothelial growth factor</topic><topic>vascular smooth muscle cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Haiyan</creatorcontrib><creatorcontrib>He, Cancan</creatorcontrib><creatorcontrib>Bi, Yang</creatorcontrib><creatorcontrib>Zhu, Xu</creatorcontrib><creatorcontrib>Deng, Dan</creatorcontrib><creatorcontrib>Ran, Tingting</creatorcontrib><creatorcontrib>Ji, Xiaojuan</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Haiyan</au><au>He, Cancan</au><au>Bi, Yang</au><au>Zhu, Xu</au><au>Deng, Dan</au><au>Ran, Tingting</au><au>Ji, Xiaojuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synergistic effect of VEGF and SDF-1α in endothelial progenitor cells and vascular smooth muscle cells</atitle><jtitle>Frontiers in pharmacology</jtitle><date>2022-07-15</date><risdate>2022</risdate><volume>13</volume><spage>914347</spage><epage>914347</epage><pages>914347-914347</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract>Vascular endothelial growth factor (VEGF) is a potent agonist of angiogenesis that induces proliferation and differentiation of endothelial progenitor cells (EPCs) after vascular injury. Previous studies have suggested that stromal cell-derived factor 1-alpha (SDF-1α) and VEGF have a synergistic effect on vascular stenosis. The aim of the present study was to investigate whether VEGF and SDF-1α act synergistically in EPCs and vascular smooth muscle cells (VSMCs). In this study, EPCs were isolated from rat bone marrow and their morphology and function were studied. Subsequently, VEGF was delivered into EPCs using an adenoviral vector. Tube formation, migration, proliferation, and apoptosis of VEGF-overexpressing EPCs was analyzed. Then, EPCs were co-cultured with VSMCs in the presence or absence of SDF-1α, the migration, proliferation, apoptosis, and differentiation capacity of EPCs and VSMCs were analyzed respectively. The isolated EPCs showed typical morphological features, phagocytic capacity, and expressed surface proteins. While stable expression of VEGF remarkably enhanced tube formation, migration, and proliferation capacity of EPCs, apoptosis was decreased. Moreover, the proliferation, migration, and differentiation capacity of EPCs in the co-cultured model was enhanced in the presence of SDF-1α, and apoptosis was decreased. However, these effects were reversed in VSMCs. Therefore, our results showed that VEGF and SDF-1α synergistically increased the migration, differentiation, and proliferation capabilities of EPCs, but not VSMCs. This study suggests a promising strategy to prevent vascular stenosis.</abstract><pub>Frontiers Media S.A</pub><pmid>35910392</pmid><doi>10.3389/fphar.2022.914347</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2022-07, Vol.13, p.914347-914347
issn 1663-9812
1663-9812
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_49ed786a0fe64710bc7ca4e29069b76e
source Open Access: PubMed Central
subjects endothelial progenitor cell
Pharmacology
stromal cell-derived factor-1α
synergistic effect
vascular endothelial growth factor
vascular smooth muscle cells
title Synergistic effect of VEGF and SDF-1α in endothelial progenitor cells and vascular smooth muscle cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T15%3A44%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synergistic%20effect%20of%20VEGF%20and%20SDF-1%CE%B1%20in%20endothelial%20progenitor%20cells%20and%20vascular%20smooth%20muscle%20cells&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Yang,%20Haiyan&rft.date=2022-07-15&rft.volume=13&rft.spage=914347&rft.epage=914347&rft.pages=914347-914347&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2022.914347&rft_dat=%3Cproquest_doaj_%3E2697091823%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-ad2e13759f2cb2ef79e0817704a9473c0f285c6ca1f2bb87087e7a71c96a21f83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2697091823&rft_id=info:pmid/35910392&rfr_iscdi=true